Navigation Links
InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
Date:11/5/2009

toward an expected IND filing in 2010. -- G&A expense: anticipated to be in a range of approximately $35 to $40 million. The G&A guidance range includes approximately $5.0 million of various pirfenidone pre-launch costs.

Conference Call and Webcast Details

InterMune will host a conference call today at 4:30 p.m. EST to discuss its financial results for its third quarter and first nine months of 2009, its forward-looking financial guidance and its clinical development programs. Interested investors and others may participate in the conference call by dialing 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 37626791. A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 37626791. The webcast will remain available on the company's website until the next earnings call.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which InterMune has completed a Phase 3 program in patients with IPF (CAPACITY) and has submitted a New Drug Application (NDA) to the FDA. The hepatology portfolio includes the HCV protease inhibitor compo
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015  Integrative medicine interventions lead to ... for chronic pain, depression, and stress, according to ... The Bravewell Collaborative . The findings are based ... Medicine Interventions Effectiveness Registry (PRIMIER), the first-ever patient ... from PRIMIER , researchers found that the ...
(Date:5/6/2015)... BETHESDA, Md. , May 6, 2015 ... announced that it has finalized agreement with Richard ... through 2021. "We are very pleased to ... and CEO," said Hal Baseman , the Chair ... enjoyed significant success, performance and growth.  Richard has led ...
(Date:5/6/2015)... May 6, 2015 Saint-Gobain has ... manufacture of filtration products, mainly for the life sciences ... filters manufactured in a state-of-the-art plant in ... sold across the globe and will bolster the range ... This acquisition is fully in line with the ...
Breaking Medicine Technology:Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2
... International Foundation for Sonography Education and Research (IFSER) ... the mSCAN (mobile Sonography Clinical Assessment Notebook). Its ... developed by IFSER in 1994, and is the ... sonography. Based on sound research and analysis, the ...
... 27 CutisPharma, Inc. today announced that it has ... Office for its patent (US 7,815,929) regarding a method ... "By its very nature, the process of ... adequate compensation," said Dr. Indu Muni, founder, chairman, and ...
Cached Medicine Technology:IFSER: Introducing the mSCAN 2CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding 2
(Date:5/6/2015)... May 05, 2014 (PRWEB) May 06, 2015 ... Lock accepted, on behalf of MEBC, an Alliance ... from JDA Software during FOCUS 2015, JDA’s annual ... across the manufacturing, retail and wholesale distribution sectors. ... that their clients are receiving services that advance ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Beryl ... 1 of Patient Experience Journal (PXJ), an international, ... practices around understanding and improving patient experience. The second ... patient experience conversation globally, helps align the voices engaged ... , Published in association with The Beryl Institute, ...
(Date:5/6/2015)... Angeles (PRWEB) May 06, 2015 ... the #1 ranked international water, sanitation and hygiene nonprofit ... for communities across the world and it brings our ... Carnett, CEO of Marketing Maven. “The ongoing relationship between ... opportunities available for people to learn about and support ...
(Date:5/6/2015)... 06, 2015 Wolters Kluwer , ... and students, announced today that in a survey of ... use of the clinical decision support resource improves the ... of 2014, UpToDate users in more than 170 countries ... month, on average. In Germany alone, 95% of all ...
(Date:5/6/2015)... has opened press registration for TU-Automotive Detroit as the ... headlines of major publications world-wide. With 150+ speakers from ... to share their visions for the future of connected ... to go behind the scenes and hear major automakers’ ... year we’re releasing a preview of all the major ...
Breaking Medicine News(10 mins):Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2
... , HOUSTON, Aug. 6 US Oncology, Inc. ("US ... reported revenue of $881.6 million, EBITDA of $39.9 million, Adjusted EBITDA of $62.7 ... for the three months ended June 30, 2009. , , ... , Adjusted EBITDA for the second quarter of ...
... , WALTHAM, Mass., Aug. 6 ... and advisory firms for pharmaceutical and healthcare issues, today ... which now includes patient share and sales forecasts through ... disodium (R788). The report update is based on Rigel ...
... , , , , ... it,s easy for their owners to get caught up in work, family ... for regular annual exams. In a recent national survey conducted in ... than one-third of respondents claimed to only bring their cats to the ...
... , , , -Window ... , , NEW YORK, Aug. 6 The ... EHE International to raise awareness of the fight against Parkinson,s disease. For ... space at 10 Rockefeller Plaza to showcase the many ways that ordinary ...
... , SOUTH SAN FRANCISCO, Calif., Aug. 6 ... of drug discovery and development through the application of cellular reprogramming, ... Hochedlinger to the company,s Scientific Advisory Board (SAB). , , ... cell research and their addition to the iPierian SAB rounds out ...
... , ATLANTA, Aug. 6 Although ... vacation, it is actually exam time here in Georgia. Don,t fret, the ... office instead of the traditional classroom, and should take place before or ... a routine doctor,s exam to confirm that all immunizations are up-to-date, a ...
Cached Medicine News:Health News:US Oncology Reports Second Quarter Operating Results 2Health News:US Oncology Reports Second Quarter Operating Results 3Health News:US Oncology Reports Second Quarter Operating Results 4Health News:US Oncology Reports Second Quarter Operating Results 5Health News:US Oncology Reports Second Quarter Operating Results 6Health News:US Oncology Reports Second Quarter Operating Results 7Health News:US Oncology Reports Second Quarter Operating Results 8Health News:US Oncology Reports Second Quarter Operating Results 9Health News:US Oncology Reports Second Quarter Operating Results 10Health News:US Oncology Reports Second Quarter Operating Results 11Health News:US Oncology Reports Second Quarter Operating Results 12Health News:US Oncology Reports Second Quarter Operating Results 13Health News:US Oncology Reports Second Quarter Operating Results 14Health News:US Oncology Reports Second Quarter Operating Results 15Health News:US Oncology Reports Second Quarter Operating Results 16Health News:US Oncology Reports Second Quarter Operating Results 17Health News:US Oncology Reports Second Quarter Operating Results 18Health News:US Oncology Reports Second Quarter Operating Results 19Health News:US Oncology Reports Second Quarter Operating Results 20Health News:US Oncology Reports Second Quarter Operating Results 21Health News:US Oncology Reports Second Quarter Operating Results 22Health News:US Oncology Reports Second Quarter Operating Results 23Health News:US Oncology Reports Second Quarter Operating Results 24Health News:US Oncology Reports Second Quarter Operating Results 25Health News:Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium 2Health News:Feline Pine Announces National 'Take Your Cat to the Vet Day' August 22 2Health News:EHE International Supports The Michael J. Fox Foundation for Parkinson's Research 2Health News:iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board 2Health News:Is it Exam Time for Georgia's School Children Already? 2Health News:Is it Exam Time for Georgia's School Children Already? 3Health News:Is it Exam Time for Georgia's School Children Already? 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: